ロード中...
Combinational treatment of gap junctional activator and tamoxifen in breast cancer cells
INTRODUCTION: Tamoxifen is a drug of choice for endocrine-responsive breast tumor patients. However, tamoxifen resistance has become a major concern for the treatment of breast cancer. Combinational therapies of tamoxifen and different drugs are being frequently studied. In the current study, we tes...
保存先:
| 出版年: | Anticancer Drugs |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2010
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4378591/ https://ncbi.nlm.nih.gov/pubmed/19966541 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CAD.0b013e328333d557 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|